RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Talkmed Group Revenue 2024

Talkmed Group Revenue

67.03 M SGD

Talkmed Group Dividend yield

6.08 %

Ticker

5G3.SI

ISIN

SG2G61000003

In 2024, Talkmed Group's sales reached 67.03 M SGD, a -20.01% difference from the 83.79 M SGD sales recorded in the previous year.

The Talkmed Group Revenue history

YEARREVENUE (undefined SGD)GROSS MARGIN (%)
2024e67.0370,06
202383.7956,04
202276.661,31
202160.7557,12
202062.1475,58
201975.9261,86
201861.2876,63
201761.3676,53
201668.9168,14
201565.7271,46
201463.1774,34
201356.2783,45
201251.8690,55
201149.1495,56
201048.3497,15

Talkmed Group Aktienanalyse

What does Talkmed Group do?

Talkmed Group Ltd. is a leading healthcare company in Asia specializing in the development, manufacturing, and marketing of innovative diagnostic and therapeutic solutions in oncology. The company was founded in 2002 by Dr. Ang Peng Tiam, with a focus on providing high-quality cancer treatments. Since its inception, Talkmed Group Ltd. has become a pioneer in cancer research and treatment in Asia and has grown to become one of the largest providers of cancer treatments in the region. The company's business model is centered around offering high-quality diagnostic solutions and innovative cancer therapies to provide better patient care. They work closely with pharmaceutical companies to develop and market innovative medications and therapies that contribute to higher survival rates and improved quality of life for cancer patients. In addition, Talkmed Group Ltd. is involved in the development of medical diagnostic and monitoring devices tailored to the needs of cancer patients. They offer a range of treatments and programs that aim to provide accessible, affordable, and high-quality care for cancer patients. Overall, Talkmed Group Ltd. is an innovative company dedicated to improving the lives of cancer patients through the development, manufacturing, and marketing of diagnostic and therapeutic solutions in oncology. Talkmed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Talkmed Group's Sales Figures

The sales figures of Talkmed Group originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Talkmed Group’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Talkmed Group's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Talkmed Group’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Talkmed Group Stock

How much revenue did Talkmed Group generate this year?

Talkmed Group has achieved a revenue of 67.03 M SGD this year.

How much was the turnover of the company Talkmed Group compared to the previous year?

The revenue of Talkmed Group has increased by -20.01% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Talkmed Group?

The revenue of Talkmed Group is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Talkmed Group measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Talkmed Group so important for investors?

The revenue of Talkmed Group is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Talkmed Group pay?

Over the past 12 months, Talkmed Group paid a dividend of 0.02 SGD . This corresponds to a dividend yield of about 6.08 %. For the coming 12 months, Talkmed Group is expected to pay a dividend of 0.02 SGD.

What is the dividend yield of Talkmed Group?

The current dividend yield of Talkmed Group is 6.08 %.

When does Talkmed Group pay dividends?

Talkmed Group pays a quarterly dividend. This is distributed in the months of September, May, September, May.

How secure is the dividend of Talkmed Group?

Talkmed Group paid dividends every year for the past 11 years.

What is the dividend of Talkmed Group?

For the upcoming 12 months, dividends amounting to 0.02 SGD are expected. This corresponds to a dividend yield of 6.08 %.

In which sector is Talkmed Group located?

Talkmed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Talkmed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Talkmed Group from 5/10/2024 amounting to 0.013 SGD, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.

When did Talkmed Group pay the last dividend?

The last dividend was paid out on 5/10/2024.

What was the dividend of Talkmed Group in the year 2023?

In the year 2023, Talkmed Group distributed 0.024 SGD as dividends.

In which currency does Talkmed Group pay out the dividend?

The dividends of Talkmed Group are distributed in SGD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Talkmed Group

Our stock analysis for Talkmed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Talkmed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.